Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Eloria

Belle Health
Graded #48

Higher grade

vs+11.400000000000006
Eloria
Graded #214

Lower grade

The verdict

Belle Health takes it — 77/100 to 65.6/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +43
92
49
Dose & formulationEloria +4
72
76
Clinical oversightEloria +8
71
79
Labs & monitoringBelle Health +20
72
52
FulfillmentBelle Health +4
85
81
Contract termsEloria +6
55
61
Belle Health · left barEloria · right bar

The numbers

MetricBelle HealthEloria
WeighScore77/10065.6/100
GradeC+C
Scorecard rank#48#214
Semaglutide$119/mo$179/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Eloria

Graded #214 · C

Strengths

  • Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
  • Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
  • Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
  • HSA/FSA accepted, free shipping on every order, and 24/7 support
  • Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)

Where it loses points

  • Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
  • State availability varies and is not published - only where providers are licensed and pharmacies can dispense
  • The compounding pharmacy partner is not named (US-licensed pharmacies only)
  • No LegitScript certification displayed
  • Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard